The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
Human autoimmune diseases: a comprehensive update
Abstract
There have been significant advances in our understanding of human autoimmunity that have led to improvements in classification and diagnosis and, most importantly, research advances in new therapies. The importance of autoimmunity and the mechanisms that lead to clinical disease were first recognized about 50 years ago following the pioneering studies of Macfarlane Burnett and his Nobel Prize‐winning hypothesis of the ‘forbidden clone’. Such pioneering efforts led to a better understanding not only of autoimmunity, but also of lymphoid cell development, thymic education, apoptosis and deletion of autoreactive cells. Contemporary theories suggest that the development of an autoimmune disease requires a genetic predisposition and environmental factors that trigger the immune pathways that lead, ultimately, to tissue destruction. Despite extensive research, there are no genetic tools that can be used clinically to predict the risk of autoimmune disease. Indeed, the concordance of autoimmune disease in identical twins is 12–67%, highlighting not only a role for environmental factors, but also the potential importance of stochastic or epigenetic phenomena. On the other hand, the identification of cytokines and chemokines, and their cognate receptors, has led to novel therapies that block pathological inflammatory responses within the target organ and have greatly improved the therapeutic effect in patients with autoimmune disease, particularly rheumatoid arthritis. Further advances involving the use of multiplex platforms for diagnosis and identification of new therapeutic agents should lead to major breakthroughs within the next decade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–242 of 242
Diogo, D., Okada, Y., & Plenge, R. M. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000012 · Cited by 61
Hoffmanová, I., Sánchez, D., Hábová, V., Anděl, M., Tučková, L., & Tlaskalová-Hogenová, H. (2015) · Physiological Research · doi:10.33549/physiolres.932916 · Cited by 61
Colafrancesco, S., Perricone, C., Priori, R., Valesini, G., & Shoenfeld, Y. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.03.003 · Cited by 59
Denizot, J., Desrichard, A., Agus, A., Uhrhammer, N. A., Dreux, N., Vouret‐Craviari, V., Hofman, P. M., Darfeuille–Michaud, A., & Barnich, N. (2014) · Gut · doi:10.1136/gutjnl-2014-306944 · Cited by 59
Genetic basis of rheumatoid arthritis: A current review
Kochi, Y., Suzuki, A., & Yamamoto, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.085 · Cited by 58
He, J.-F. (2014) · Medical Science Monitor · doi:10.12659/msm.890686 · Cited by 57
Genetics of rheumatoid arthritis in Asia—present and future
Yamamoto, K., Okada, Y., Suzuki, A., & Kochi, Y. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.7 · Cited by 56
Shifting T‐cell activation thresholds in autoimmunity and determinant spreading
Lehmann, P., Targoni, O. S., & Forsthuber, T. G. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01207.x · Cited by 56
Breach of Tolerance: Primary Biliary Cirrhosis
Wang, L., Chang, C. C.-C., Gershwin, M. E., & Wang, F. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1383729 · Cited by 55
Self-citationSafety of vaccine adjuvants: Focus on autoimmunity
van der Laan, J. W., Gould, S., & Tanir, J. Y. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.073 · Cited by 53
Targeting Apoptosis in Autoimmune Hepatitis
Czaja, A. J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3284-2 · Cited by 51
Wiede, F., Ziegler, A. I., Zehn, D., & Tiganis, T. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.05.008 · Cited by 49
The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus
Miao, C., Yang, Y., He, X., Huang, C. Z., Huang, Y., Zhang, L., Lv, X., Jin, Y. J., & Li, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.006 · Cited by 48
Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens.
Duke, R. C. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.1.59 · Cited by 48
Song, S.-N. J., & Yoshizaki, K. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.992779 · Cited by 47
Zhang, Y., Zhang, J., Yang, J., Wang, Y., Zhang, L., Zuo, X., Sun, L., Pan, H., Hirankarn, N., Wang, T.-Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu429 · Cited by 47
Genetics and epigenetics of primary biliary cirrhosis
Bianchi, I., Carbone, M., Lleo, A., & Invernizzi, P. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1383725 · Cited by 45
Nasonov, E. L., Soloviev, S. K., Davidson, J., et al. (2013) · Lupus · doi:10.1177/0961203313512881 · Cited by 43
Hormones and AID: Balancing immunity and autoimmunity
Incorvaia, E., Sicouri, L., Petersen‐Mahrt, S. K., & Schmitz, K.-M. (2012) · Autoimmunity · doi:10.3109/08916934.2012.748752 · Cited by 41
The Natural History of Primary Biliary Cirrhosis
Imam, M. H., & Lindor, K. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1383731 · Cited by 41
Epidemiology and treatment of autoimmune hepatitis
Michielsen, P. P., Francque, Vonghia, L., & Ramón (2012) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s16321 · Cited by 40
MicroRNA-21 with therapeutic potential in autoimmune diseases
Xu, W., Pan, H., Li, J., & Ye, D. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.773311 · Cited by 38
MiR-29a promotes intestinal epithelial apoptosis in ulcerative colitis by down-regulating Mcl-1.
Lv, B., Liu, Z., Wang, S., Liu, F., Yang, X., Hou, J., Hou, Z., & Chen, B. (2014) · International Journal of Clinical and Experimental Pathology · Cited by 37
Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease
Brønstad, I., Wolff, A. S. B., Løvås, K., Knappskog, P. M., & Husebye, E. S. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-111 · Cited by 35
Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients
MORSHED, S. A., Nishioka, M., Saito, I., Komiyama, K., & Moro, I. (1992) · Gastroenterologia Japonica · doi:10.1007/bf02806528 · Cited by 34
What have we learned from six years of GWAS in autoimmune diseases, and what is next?
Hu, X., & Daly, M. J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.09.001 · Cited by 34
Cytomegalovirus infection in childhood-onset systemic lupus erythematosus
Rozenblyum, E., Allen, U., Silverman, E. D., & Levy, D. M. (2013) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.12.82 · Cited by 34
Current Concepts and Advances in Clinical Laboratory Testing for Autoimmune Diseases
Hang, L. M., Nakamura, R. M., & Tubbs, R. (1997) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369708998095 · Cited by 33
Association of polymorphisms in non-classic MHC genes with susceptibility to autoimmune hepatitis.
Tang, J., Zhou, C., Zhang, Z.-J., & Zheng, S.-S. (2012) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/s1499-3872(12)60136-2 · Cited by 33
Andrade, F., Casciola-Rosen, L. A., & Rosen, A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20992 · Cited by 32
Ekblom-Kullberg, S., Kautiainen, H., Alha, P., Leirisalo‐Repo, M., Miettinen, A., & Julkunen, H. A. (2013) · Rheumatology International · doi:10.1007/s00296-013-2889-7 · Cited by 32
Azathioprine in Multiple Sclerosis
Invernizz, P., Benedetti, M. D., Poli, S., et al. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708785132756 · Cited by 31
Glucocorticoid treatment in rheumatoid arthritis
Rau, R. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.922955 · Cited by 31
Monogenic autoimmune diseases — lessons of self-tolerance
Ulmanen, I., Halonen, M., Ilmarinen, T., & Peltonen, L. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.09.006 · Cited by 30
Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis
Meng, Y., Li, D., Yanbin, P., Jinju, F., Meile, T., Lu, B., Xiao, H., Ping, T., & Jian-min, L. (2014) · Clinical and Experimental Dermatology · doi:10.1111/ced.12390 · Cited by 30
Epigenetics and Autoimmune Diseases
Zouali, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00028-9 · Cited by 27
Huang, R., Yin, J., Chen, Y., Deng, F., Chen, J., Gao, X., Liu, Z., Yu, X., & Zheng, J. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.11.006 · Cited by 25
Altered DNA methylation profile in Norwegian patients with Autoimmune Addison's Disease
Bjanesoy, T. E., Kulle, B., Bratland, E., Reiner, A. H., Islam, S., Husebye, E. S., & Bakke, M. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.02.018 · Cited by 19
MicroRNAs: an epigenetic tool to study celiac disease.
Bascuñán, K. A., Araya-Quezada, M., & Pérez‐Bravo, F. (2014) · PubMed · Cited by 17
Epstein–Barr virus in multiple sclerosis
Abdelrahman, H. S., Selim, H. S., Hashish, M. H., & Sultan, L. I. (2014) · Journal of the Egyptian Public Health Association · doi:10.1097/01.epx.0000452287.65133.fc · Cited by 11
Endo, T., & Kobayashi, T. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.02.004 · Cited by 10
Diagnosing coeliac disease in children
Paul, S. P., & Spray, C. H. (2014) · British Journal of Hospital Medicine · doi:10.12968/hmed.2014.75.5.268 · Cited by 8
Cited by
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
Xu, X., Pang, Y., & Fan, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02253-4 · Cited by 800
Neutrophils in chronic inflammatory diseases
Herrero-Cervera, A., Soehnlein, O., & Kenne, E. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00832-3 · Cited by 695
Miller, F. W. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102266 · Cited by 516
Macrophage polarization: an important role in inflammatory diseases
Luo, M., Zhao, F., Cheng, H., Su, M., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352946 · Cited by 468
Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
Bittner, B., Richter, W., & Schmidt, J. (2018) · BioDrugs · doi:10.1007/s40259-018-0295-0 · Cited by 447
Metadata
- Authors
- Wang, L., Wang, F., & Gershwin, M. E.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2015-07-25
- Volume
- 278
- Issue
- 4
- Pages
- 369-395
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W1540298277
- Cited by
- 1,168
- References
- 242
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.